Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign, Systematic Review and Individual Patient Meta-Analysis
Neurol 103:e210104, Yassi,N.,et al, 2024
Out-of-Hospital Tranexamic Acid for Traumatic Brain Injury
JAMA 324:946-947, Cone, D.C.,et al, 2020
Effects of Tranexamic Acid on Death, Disability, Vascular Occlusive Events and Other Morbidities in Patients with Acute Traumatic Brain Injury (CRASH-3): A Randomised, Placebo-Controlled Trial
Lancet 394:1713-1723,1687, The CRASH-3 trial collaborators, 2019
Intracerebral Haemorrhage: Current Approaches to Acute Management
Lancet 392:1257-1268, Cordonnier, C.,et al, 2018
Tranexamic Acid-Associated Seizures: Causes and Treatment
Ann Neurol 79:18-26, Lecker, I.,et al, 2016
Subarachnoid Haemorrhage
BMJ 333:235-240, Al-Shahi,R.,et al, 2006
Antifibrinolytic Therapy for Aneurysmal Subarachnoid Hemorrhage, A Major Update of a Cochrane Review
Stroke 34:2308-2309, Roos,Y.,et al, 2003
Tranexamic Acid in Hereditary Hemorrhagic Telangiectasia
NEJM 346:457, Sabra,C.,et al, 2002
Antifibrinolytic Treatment in Subarachnoid Hemorrhage, A Randomized Placebo-Controlled Trial
Neurol 54:77-82, Roos,Y.,STAR Study Group, 2000
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke 25:2315-2328, Mayberg,M.R.,et al, 1994
Cerebral Sinus Thrombosis as a Potential Hazard of Antifibrinolytic Treatment in Menorrhagia
Stroke 21:817-819, Achiron,A.,et al, 1990
Combination of Aminocaproic Acid & Nicardipine in Treatment of Aneurysmal Subarachnoid Hemorrhage
Stroke 19:63-67, Beck,D.W.,et al, 1988
Antifibrinolytics in Subarachnoid Hemorrhage, Do They Have a Role? No
Arch Neurol 44:116-118, Weir,B., 1987
Antifibrinolytics in Aneurysmal Subarachnoid Hemorrhage, Do They Have a Role? Maybe
Arch Neurol 44:114-115, 1181987., Adams,H.P., 1987
Antifibrinolytic Treatment in Subarachnoid Hemorrhage
NEJM 311:432-437, Vermeulen,M.,et al, 1984
Current Status of Antifibrinolytic Therapy for Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage
Jr. , Stroke 13:256-259982., Adams,H.P., 1982
Antifibrinolytic Therapy in Patients With Aneurysmal Subarachnoid Hemorrhage
Jr. , et al, Arch Neurol 38:25-2981., Adams,H.P., 1981
Antifibrinolytic Therapy in Subarachnoid Hemorrhage Caused by Ruptured Intracranial Aneurysm
Neurol 31:316-322, Ramirez-Lassepas,M., 1981
Management of Cerebral Aneurysm
Stroke 12:273-283, Drake,C.G.,et al, 1981
Myopathy Due to Epsilon Amino-Caproic Acid
Muscle & Nerve 3:202-206980., Kennard,C.,et al, 1980
Treatment of Subarachnoid Hemorrhage from Ruptured Intracranial Aneurysm with Tranexamic Acid:A Double-blind Clinical Trial
Ann Neurol 3:502, Chandra,B., 1978
Effect of Tranexamic Acid on Rebleeding after Subarachnoid Hemorrhage:A Double-blind Controlled Clinical Trial
Ann Neurol 2:242, vanRossum,J.,et al, 1977
A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026
Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia
Neurol 106:e214622, German,A.,et al, 2026
Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026
Peripheral Neuropathy, A Review
JAMA 335:255-266, Mauermann,M.L. & Staff,N.P., 2026
Increased Prevalence of Nitrous Oxide-Induced Subacute Combined Degeneration of the Spinal Cord: Clinical and Imaging Findings
AJNR 47:513-520, Bruen,R.,et al, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
Intranasal Selectracetam in a Patient with Reading Epilepsy:First-In-Human Use to Prevent Reflex Seizures
Ann Neurol 99:535-539, Koepp,M.J.,et al, 2026
Restless Legs Syndrome, A Review
JAMA 335:703-714, Winkelmen,J.W. & Wipper, B., 2026
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Iatrogenic Cerebral Amyloid Angiopathy after Cardiac Surgery, Two Case Reports
Neurol 106:e214819, Brunet de Courssou,J-B.,et al, 2026
Patterns and Factors Associated with Cerebral Infarction on MRi in Tuberculous Meningitis: Secondary Anlysis of the ACT-TBM Trial
Stroke 57:856-864, Chandu,M.,et al, 2026
A 67-Year-Old Man with Exercise Intolerance nd Progressive Weakness
Neurol 106:e214830, Gosset,A.,et al, 2026
Left Atrial Appendage Closure - Another Overused Method in Cardiology?
NEJM 394:1336-1338, Widimsky,P, 2026
Asundexian for Secondary Stroke Prevention
NEJM 394:1467-1479, 1540, Sharm,M.,et al, 2026
Large Language Model Performance and Clinical Reasoning Tasks
JAMA Netw Open 9:e264003, Rao,A.S.,et al, 2026
Bilateral Posterior Limb Internal Capsule T2 Hyperintensity and Severe Cerebellar Atrophy in 2 Lifelong Friends
Neurol 106:e218014, Inoue,H.,et al, 2026
Status Epilepticus After Carotid Endarterectomy:An Illustrative Case of Cerebral Hyperfusion Syndrome
Stroke 57:e188-191, Reuter,P.,et al, 2026
Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy
Neurol 106:e214864, Dhivagaran,T.,et al, 2026
Endovascular Venous Sinus Stenting versus CSF Shunting for Idiopathic Intracranial Hypertssion:Nationwide Real-World Outcomes
AJNR 47:1238-1243, Chen,H.,et al, 2026
Cerebral Amyloid Angiopathy
NEJM 394:1836-1845, Greenberg,S.M., 2026
Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026
A Woman with Parkinson Disease, Dyskinesia, Rhadomyolysis, Subcutaneous Emphysema, and Pneumomediastinum
Neurol 106:e218064, Iqbal,M.M.,et al, 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
Wearable Technology and Its Role in Neurologic Care, Emerging Issues in Neurology
Neurol 106:e214802, Benish,S.M.,et al, 2025
Anti-NMDAR Encephalitis Triggered by EBV and HSV-1
Medicine 104:28, Zhan,X.,et al, 2025